FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029041730> ?p ?o ?g. }

• W2029041730 endingPage "266" @default.
• W2029041730 startingPage "259" @default.
• W2029041730 abstract "Background: Peroxisome proliferator-activated receptor-γ (PPAR-γ) is expressed in certain human cancers. Ligand-induced PPAR-γ activation can result in growth inhibition and differentiation in these cancer cells; however, the precise mechanism for the anti-proliferative effect of PPAR-γ ligands is not clear. Methods: In this study, we examined the expression of PPAR-γ in human prostate cancer and the effect of two PPAR-γ ligands, 15 deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) and troglitazone, on prostate cancer cell growth. Results: PPAR-γ is frequently over-expressed in androgen independent prostate cancer cell lines and human prostate cancer tissues (22 of 47; 47%). Both 15d-PGJ2 and troglitazone inhibited proliferation and DNA synthesis of prostate cancer cell lines in a dose-dependent manner, and slightly increased the proportion of cells with S-phase DNA content. Prostate specific antigen (PSA) promoter reporter assays showed that troglitazone and 15d-PGJ2 down-regulated androgen stimulated reporter gene activity in prostate cancer cell lines LNCaP. Interestingly, LNCaP with troglitazone dramatically suppressed PSA protein expression without suppressing AR expression. Conclusions: Taken together, these results suggest that PPAR-γ ligands may be a useful therapeutic agent for the treatment of prostate cancer." @default.
• W2029041730 created "2016-06-24" @default.
• W2029041730 creator A5012278399 @default.
• W2029041730 creator A5015707552 @default.
• W2029041730 creator A5016484890 @default.
• W2029041730 creator A5021912106 @default.
• W2029041730 creator A5028059624 @default.
• W2029041730 creator A5034145502 @default.
• W2029041730 creator A5073925535 @default.
• W2029041730 creator A5091003441 @default.
• W2029041730 date "2008-01-01" @default.
• W2029041730 modified "2023-09-26" @default.
• W2029041730 title "Peroxisome proliferator-activated receptor-γ and growth inhibition by its ligands in prostate cancer" @default.
• W2029041730 cites W1951826532 @default.
• W2029041730 cites W1971056997 @default.
• W2029041730 cites W1974063618 @default.
• W2029041730 cites W1993342645 @default.
• W2029041730 cites W1999513011 @default.
• W2029041730 cites W2000741688 @default.
• W2029041730 cites W2008557193 @default.
• W2029041730 cites W2024722389 @default.
• W2029041730 cites W2031694725 @default.
• W2029041730 cites W2034074585 @default.
• W2029041730 cites W2070851174 @default.
• W2029041730 cites W2089162704 @default.
• W2029041730 cites W2092961460 @default.
• W2029041730 cites W2093519703 @default.
• W2029041730 cites W2099734818 @default.
• W2029041730 cites W2109694492 @default.
• W2029041730 cites W2114437978 @default.
• W2029041730 cites W2114553620 @default.
• W2029041730 cites W2124100109 @default.
• W2029041730 cites W2126898107 @default.
• W2029041730 cites W2132665968 @default.
• W2029041730 cites W2154114022 @default.
• W2029041730 cites W2166557975 @default.
• W2029041730 cites W2172256092 @default.
• W2029041730 cites W4321428114 @default.
• W2029041730 cites W4366455030 @default.
• W2029041730 cites W63697704 @default.
• W2029041730 doi "https://doi.org/10.1016/j.cdp.2008.05.008" @default.
• W2029041730 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18789607" @default.
• W2029041730 hasPublicationYear "2008" @default.
• W2029041730 type Work @default.
• W2029041730 sameAs 2029041730 @default.
• W2029041730 citedByCount "26" @default.
• W2029041730 countsByYear W20290417302012 @default.
• W2029041730 countsByYear W20290417302013 @default.
• W2029041730 countsByYear W20290417302014 @default.
• W2029041730 countsByYear W20290417302015 @default.
• W2029041730 countsByYear W20290417302016 @default.
• W2029041730 countsByYear W20290417302017 @default.
• W2029041730 countsByYear W20290417302021 @default.
• W2029041730 countsByYear W20290417302023 @default.
• W2029041730 crossrefType "journal-article" @default.
• W2029041730 hasAuthorship W2029041730A5012278399 @default.
• W2029041730 hasAuthorship W2029041730A5015707552 @default.
• W2029041730 hasAuthorship W2029041730A5016484890 @default.
• W2029041730 hasAuthorship W2029041730A5021912106 @default.
• W2029041730 hasAuthorship W2029041730A5028059624 @default.
• W2029041730 hasAuthorship W2029041730A5034145502 @default.
• W2029041730 hasAuthorship W2029041730A5073925535 @default.
• W2029041730 hasAuthorship W2029041730A5091003441 @default.
• W2029041730 hasConcept C104317684 @default.
• W2029041730 hasConcept C121608353 @default.
• W2029041730 hasConcept C126322002 @default.
• W2029041730 hasConcept C134018914 @default.
• W2029041730 hasConcept C150194340 @default.
• W2029041730 hasConcept C161733203 @default.
• W2029041730 hasConcept C170493617 @default.
• W2029041730 hasConcept C185592680 @default.
• W2029041730 hasConcept C187345961 @default.
• W2029041730 hasConcept C2778150266 @default.
• W2029041730 hasConcept C2779723316 @default.
• W2029041730 hasConcept C2780192828 @default.
• W2029041730 hasConcept C2780963305 @default.
• W2029041730 hasConcept C502942594 @default.
• W2029041730 hasConcept C55493867 @default.
• W2029041730 hasConcept C61367390 @default.
• W2029041730 hasConcept C62112901 @default.
• W2029041730 hasConcept C71924100 @default.
• W2029041730 hasConcept C86803240 @default.
• W2029041730 hasConcept C96232424 @default.
• W2029041730 hasConceptScore W2029041730C104317684 @default.
• W2029041730 hasConceptScore W2029041730C121608353 @default.
• W2029041730 hasConceptScore W2029041730C126322002 @default.
• W2029041730 hasConceptScore W2029041730C134018914 @default.
• W2029041730 hasConceptScore W2029041730C150194340 @default.
• W2029041730 hasConceptScore W2029041730C161733203 @default.
• W2029041730 hasConceptScore W2029041730C170493617 @default.
• W2029041730 hasConceptScore W2029041730C185592680 @default.
• W2029041730 hasConceptScore W2029041730C187345961 @default.
• W2029041730 hasConceptScore W2029041730C2778150266 @default.
• W2029041730 hasConceptScore W2029041730C2779723316 @default.
• W2029041730 hasConceptScore W2029041730C2780192828 @default.
• W2029041730 hasConceptScore W2029041730C2780963305 @default.
• W2029041730 hasConceptScore W2029041730C502942594 @default.
• W2029041730 hasConceptScore W2029041730C55493867 @default.

• next